title: Hybrid peptides having mixed substance P (NK1), neurokinin A (NK2) and bradykinin (BK2) antagonist properties.
authors.affiliation: Cortech, Inc., Denver, CO 80221, USA.
authors.forename: V P
authors.initials: VP
authors.lastname: Srivastava
authors.forename: V S
authors.initials: VS
authors.lastname: Goodfellow
authors.forename: J S
authors.initials: JS
authors.lastname: Zuzack
authors.forename: S
authors.initials: S
authors.lastname: Jones
authors.forename: M
authors.initials: M
authors.lastname: Francis
authors.forename: V E
authors.initials: VE
authors.lastname: Beckey
authors.forename: E T
authors.initials: ET
authors.lastname: Whalley
mesh_terms: D000818:Animals; D001920:Bradykinin / Q000037:antagonists & inhibitors*; D065168:Bradykinin Receptor Antagonists; D006168:Guinea Pigs; D006801:Humans; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D015394:Molecular Structure; D015288:Neurokinin A / Q000037:antagonists & inhibitors*; D064729:Neurokinin-1 Receptor Antagonists; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology*; D011651:Pulmonary Artery / Q000187:drug effects; D011817:Rabbits; D043782:Receptor, Bradykinin B2; D018041:Receptors, Neurokinin-2 / Q000037:antagonists & inhibitors; D013329:Structure-Activity Relationship; D013373:Substance P / Q000037:antagonists & inhibitors*
chemical_list: D065168:Bradykinin Receptor Antagonists; D064729:Neurokinin-1 Receptor Antagonists; D009842:Oligopeptides; D043782:Receptor, Bradykinin B2; D018041:Receptors, Neurokinin-2; D013373:Substance P; D015288:Neurokinin A; D001920:Bradykinin